ArticleCommunications medicine2025
The effect of TPOAb on pregnancy outcomes among people with polycystic ovary syndrome with euthyroidism undergoing in vitro fertilization.
Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The effect of TPOAb on pregnancy outcomes among people with polycystic ovary syndrome with euthyroidism undergoing in vitro fertilization.Communications medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycystic ovary syndrome (PCOS) is a complex endocrine disorder and a leading cause of infertility. When accompanied by anti-thyroid peroxidase antibodies (TPOAb), PCOS patients may face an increased risk of reproductive complications. However, the impact of TPOAb on assisted reproductive technology (ART) outcomes in PCOS remains unclear. Assessing the impact of TPOAb levels on embryologic and pregnancy outcomes in IVF/ICSI cycles among euthyroid PCOS patients is crucial for identifying potential risks and refining clinical management strategies to improve reproductive outcomes.
methodsThis retrospective cohort study includes PCOS patients selected using standard diagnostic codes, strict inclusion and exclusion criteria, and propensity score matching (PSM) at a 1:4 ratio. A total of 62 TPOAb-positive PCOS patients are matched with 216 TPOAb-negative PCOS patients undergoing IVF/ICSI treatment. The primary outcomes assessed are clinical pregnancy rate and live birth rate, while secondary outcomes include other pregnancy-related outcomes and embryo quality parameters.
resultsHere we show that the TPOAb-positive group has significantly higher fertilization rate, normal fertilization (two-pronuclei, 2PN) rate, and 2PN cleavage rate after PSM (all P < 0.05). However, multivariate analyses adjusting for propensity scores reveal no significant associations between TPOAb status and any embryologic indicators. Additionally, there are no statistically significant differences between the groups in pregnancy outcomes (all P > 0.05).
conclusionsTPOAb positivity is not associated with adverse embryonic or pregnancy outcomes in euthyroid PCOS patients undergoing IVF/ICSI treatment. Therefore, the presence of TPOAb alone should not be overemphasized, nor does it warrant overtreatment in this patient population.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.